Term
|
Definition
Impulse initiation: Sinus arrest, sinus bradycardia, sinoatrial exit block.
Impulse conduction: Heart block (Types I, II, III) |
|
|
Term
|
Definition
1) Increased automaticity (impulses come from somewhere other than sinus node). EXAMPLES: Atrial Tachycardia - abnormal pulses coming from the atria. Junctional tachycardia - abnormal AV pulses.
Ventricular tachycardia - abnormal pulses coming from ventricle.
2) Triggered activities in phase 3 or 4 (repolarization). EXAMPLES: Early afterdepolarization (EAD) - interrupts phase 3. Delayed afterdepolarization (DAD) - interrupts phase 4 of AP.
3) Impulse conduction through tissues with different conductivities causing reentry circuit. |
|
|
Term
|
Definition
Atrial Tachycardia - abnormal pulses coming from the atria.
Junctional tachycardia - abnormal AV pulses.
Ventricular tachycardia - abnormal pulses coming from ventricle. |
|
|
Term
|
Definition
|
|
Term
|
Definition
Cells with conduction properties remain around tricuspid and mitral annuli during development. Conduction to ventricular tissue is faster than AV node.
Look for Delta Wave on EKG. |
|
|
Term
|
Definition
Reentry circuit around mitral, tricuspid annulus.
Fast, but regular ventricular response.
Atrial rate is ~300 bpm.
Sawtooth pattern. |
|
|
Term
|
Definition
RR (ventricular) interval is irregularly irregular with no organized p impulse. |
|
|
Term
|
Definition
NEED: 1) substrate - scar tissue, slow/fast pathway.
2) trigger - electrolyte imbalance, acid/base imbalance. |
|
|
Term
|
Definition
TREATMENT: Treat underlying cause (drugs, high vagal tone) if possible. If not, use pacemaker. |
|
|
Term
Vaughan Williams Classification System |
|
Definition
Primarily Sodium Channel Blockers:
1a) Quinidine, procainamide, disopyramide.
1b) Lidocaine, mexiletine, tocainide.
1c) Flecainide, propafenone.
2) Beta blockers
3) K channel blockers
Amiodarone, bretylium, sotalol, ibutilide, dofetilide.
4) CCBs
Verapamil, diltiazem.
NOT CLASSIFIED: Digoxin, Adenosine. |
|
|
Term
|
Definition
MECH: Acts on adenosine receptors in atrium, SA node and AV node. Activates outward K flux and inhibition of calcium current causing hyperpolarization which slows automaticity and AV conduction.
USE: Acute termination of supraventricular tachycardia (SVT).
1/2 life only 10 seconds!! Vaugh Williams 0.
|
|
|
Term
|
Definition
MECH: Na channel blocker, prolongs QRS, slowing conduction.
AE: Hypotension, lupus (with long-term treatment), inpatient only.
Metabolized to N-acetlyprocainamide which has class 3 properties (K channel blockade). Vaugh Williams 1a. |
|
|
Term
|
Definition
MECH: Blocks Na, K channels and alpha adrenergics.
USE: Atrial fibrillation. Also Brugada's syndrome (Na ion channel mutation) and short QT syndrome (K channel mutation).
AE: Naus., diarrhea, Quinidine syncope (polymorphic v-tach secondary to prolongued QT interval)--monitor patients carefully. Vaugh Williams class 1a. |
|
|
Term
|
Definition
MECH: Direct vagal blocker.
USE: Baseline bradycardia, Ventricular tachycardia.
AE: Urinary retention, blurred vision, exacerbated glaucoma (anticholinergic). Vaugh Williams class 1a. |
|
|
Term
|
Definition
MECH: Na channel blocker. Works preferentially on ischemic ventricular myocardium.
USE: Ventricular Tachycardia.
AE: neurological: tremor, slurred speach, convulsions and seizure. Metabolized in liver (therefore, IV only)--reduce dose in CHF and liver disease patients. ONLY I.V. Vaugh Williams class 1b. |
|
|
Term
|
Definition
MECH: Oral Lidocaine. Same mech.
USE: Ventricular tachycardia in ischemic tissue. Also for use in patients on drugs that prolong QT interval.
AE: GI upset. Vaugh WIlliams class 1b. |
|
|
Term
|
Definition
MECH: Potent Na channel blocker which prolongs atrial refractory time and QRS interval.
USE: Premature Ventricular Contraction (PVC), A-Fib.
CONTRA: DO NOT use in patients with CAD, cardiomyopathies or LV dysfunction.
Vaugh Williams class 1c. 5-hydroxy Propafenone is an active metabolite. |
|
|
Term
|
Definition
MECH: Potent Na channel blocker which prolongs atrial refractory time and QRS interval.
USE: Premature Ventricular Contraction (PVC), A-Fib.
CONTRA: DO NOT use in patients with CAD, cardiomyopathies or LV dysfunction.
Vaugh Williams class 1c. |
|
|
Term
|
Definition
MECH: Increase refractory time in AV node.
AE: Bronchospasm, bradycardia. |
|
|
Term
|
Definition
MECH: Blocks, K, Na, Ca and Beta receptor.
USE: Ventricular arrythmia, A-Fib.
AE: Thyroid imbalance (contains iodine), hypotension due to vasodilation. Liver, lung toxicity as well.
All 4 class actions but considered class III. |
|
|
Term
|
Definition
MECH: Like Amioderone but more tolerable due to its lack of iodine.
USE: A Fib (NOT effective in LV dysfunction).
Class III. |
|
|
Term
|
Definition
MECH: K channel blocker which prolongs Ventricular action potential (APD), prolongs Effective refractory period (ERP). Also a beta blocker.
USE: Ventricular and atrial arrythmias.
Renally adjust dosage. Class III. |
|
|
Term
|
Definition
MECH: Pure blockage of IKr channel (phase 3).
USE: A-Fib (in hospital only). Can be used for patients with A-fib and ischemic cardiomyopathy and CAD.
Potential for developing Toursades so watch QT closely. |
|
|
Term
|
Definition
MECH: IKr blocker, also activates inward Na current.
USE: Atrial flutter, Atrial Fibrillation (ONLY I.V.).
AE: 4% develop Torsades--watch carefully for 4 hrs. |
|
|
Term
|
Definition
MECH: L-type Ca channel blocker. Slows impulse in SA and AV node by increasing conduction time and increasing refractory time.
USE: SVT
AE: Negative inotrope (watch in HF), sinus arrest, AV block. |
|
|
Term
|
Definition
MECH: L-type Ca channel blocker. Slows impulse in SA and AV node by increasing conduction time and increasing refractory time.
USE: SVT
AE: Negative inotrope (watch in HF), sinus arrest, AV block. |
|
|